{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:56:47Z","timestamp":1762444607761},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_med-2016-0011_s_331_w2aab3b8c14b1b7b1aab1c14b1Aa\">\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>To investigate the magnetic diffusion weighted imaging (DWI) sequence and Spondyloarthritis Research Consortium of Canada (SPARCC) scoring in assessing curative effect of combined treatment of Chinese and Western medicine for early ankylosing spondylitis (AS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_med-2016-0011_s_332_w2aab3b8c14b1b7b1aab1c14b2Aa\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>48 cases diagnosed as early AS and treated with Chinese and Western medicine were included in the study. Magnetic routine and DWI sequence scanning image were performed to obtain the mean apparent diffusion coefficient (ADC) value of sub-articular surface bone marrow. Combined with SPARCC scoring, statistical analysis was conducted to compare the difference with the information obtained in the previous study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_med-2016-0011_s_333_w2aab3b8c14b1b7b1aab1c14b3Aa\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean ADC value in the sub-articular surface bone marrow of patients after clinical treatment: (4.34\u00b10.55)\u00d710-4mm2\/s in ilium and (3.96\u00b10.23)\u00d710-4mm2\/s in sacrum, which were both significantly lower than that before treatment (p&lt; 0.05). There was highly positive correlation between mean ADC value and SPARCC scoring (P&lt;0.05). The regression relationship could be demonstrated as Y=-64.420+21.262X(Y: SPARCC scoring value; X: mean ADC value).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_med-2016-0011_s_334_w2aab3b8c14b1b7b1aab1c14b4Aa\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Magnetic DWI and SPARCC scoring could be applied in accessing AS inflammation activity changes and in reflect of curative effect of early AS patients as well as in providing reliable radiologist evidence for clinical therapeutic efficacy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/med-2016-0011","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T15:56:48Z","timestamp":1467043008000},"page":"52-58","source":"Crossref","is-referenced-by-count":6,"title":["DWI and SPARCC scoring assess curative effect of early ankylosing spondylitis"],"prefix":"10.1515","volume":"11","author":[{"given":"Jian","family":"Qin","sequence":"first","affiliation":[{"name":"Jian Qin, Jianzhong Zhu, Yue Zhang , Division of Radiology, Taishan Medical School Affiliated Hospital, Taian, Shandong Province 271000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Jian Qin, Jianzhong Zhu, Yue Zhang , Division of Radiology, Taishan Medical School Affiliated Hospital, Taian, Shandong Province 271000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jian Qin, Jianzhong Zhu, Yue Zhang , Division of Radiology, Taishan Medical School Affiliated Hospital, Taian, Shandong Province 271000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqin","family":"Li","sequence":"additional","affiliation":[{"name":"Jian Qin, Jianzhong Zhu, Yue Zhang , Division of Radiology, Taishan Medical School Affiliated Hospital, Taian, Shandong Province 271000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"key":"2023040102562795702_j_med-2016-0011_ref_001_w2aab3b8c14b1b7b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Ga\u0161per\u0161i\u010d N., Ser\u0161a I., Jevti\u010d V., Tom\u0161i\u010d M., Praprotnik S., Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging, Skeletal Radiol, 2008, 37, 123-131","DOI":"10.1007\/s00256-007-0407-2"},{"key":"2023040102562795702_j_med-2016-0011_ref_002_w2aab3b8c14b1b7b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Ji W, Li J, Lin Y, Song YN, Zhang M, Ke Y, Ren Y, Deng X, Zhang J, Huang F, Yu D. Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii. Clin Rheumatol. 2010 Sep;29(9):1067-1072.","DOI":"10.1007\/s10067-010-1497-0"},{"key":"2023040102562795702_j_med-2016-0011_ref_003_w2aab3b8c14b1b7b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Jansen JP, Gaugris S, Choy EH, Ostor A, Nash JT, Stam W.cost effectiveness of etoricoxib versus celecoxib and non-selective nsaids in the treatment of ankylosing spondylitis. Pharmacoeconomics. 2010;28(4):323-344","DOI":"10.2165\/11314690-000000000-00000"},{"key":"2023040102562795702_j_med-2016-0011_ref_004_w2aab3b8c14b1b7b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Braun J, Zochling J, Baraliakos X, Alten R, Burmester G, Grasedyck K, Brandt J, Haibel H, Hammer M, Krause A, Mielke F, Tony HP, Ebner W, G\u00f6m\u00f6r B, Hermann J, Zeidler H, Beck E, Baumgaertner M, Sieper J.efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis. 2006 Sep;65(9):1147-1153","DOI":"10.1136\/ard.2006.052878"},{"key":"2023040102562795702_j_med-2016-0011_ref_005_w2aab3b8c14b1b7b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Ternant D, Mulleman D, Lauf\u00e9ron F, Vignault C, Ducourau E, Wendling D, Goupille P, Paintaud G.influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis. Br J Clin Pharmacol. 2012 Jan;73(1):55-65","DOI":"10.1111\/j.1365-2125.2011.04050.x"},{"key":"2023040102562795702_j_med-2016-0011_ref_006_w2aab3b8c14b1b7b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Deng X, Zhang J, Zhang J, Huang F. Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int. 2013 Jun;33(6):1409-1413","DOI":"10.1007\/s00296-012-2571-5"},{"key":"2023040102562795702_j_med-2016-0011_ref_007_w2aab3b8c14b1b7b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Dougados M, Braun J, Szanto S, Combe B, Elbaz M, Geher P, Thabut G, Leblanc V, Logeart I.Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosingspondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis. 2011 May;70(5):799-804","DOI":"10.1136\/ard.2010.139261"},{"key":"2023040102562795702_j_med-2016-0011_ref_008_w2aab3b8c14b1b7b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Park W, Hrycaj P, Jeka S, Kovalenko V, Lysenko G, Miranda P, Mikazane H, Gutierrez-Urena S, Lim M, Lee YA, Lee SJ, Kim H, Yoo DH, Braun J.A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Ann Rheum Dis. 2013 Oct;72(10):1605-1612","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"2023040102562795702_j_med-2016-0011_ref_009_w2aab3b8c14b1b7b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"van der Heijde D, Schiff MH, Sieper J, Kivitz AJ, Wong RL, Kupper H, Dijkmans BA, Mease PJ, Davis JC Jr; ATLASStudy Group. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis. 2009 Jun;68(6):922-929","DOI":"10.1136\/ard.2007.087270"},{"key":"2023040102562795702_j_med-2016-0011_ref_010_w2aab3b8c14b1b7b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Weckbach S., Schewe S., Michaely H.J., Steffinger D., Reiser M.F., Glaser C., Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making, Eur J Radiol, 2011, 77, 149-155","DOI":"10.1016\/j.ejrad.2009.06.020"},{"key":"2023040102562795702_j_med-2016-0011_ref_011_w2aab3b8c14b1b7b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Maksymowych W.P., Inman R.D., Salonen D., Dhillon S.S., Williams M., Stone M., et al., Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis, Arthritis Rtheum, 2005, 53, 703-709","DOI":"10.1002\/art.21445"},{"key":"2023040102562795702_j_med-2016-0011_ref_012_w2aab3b8c14b1b7b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"V\u00e9gv\u00e1ri A., Szab\u00f3 Z., Sz\u00e1nt\u00f3 S., Glant T.T., Mikecz K., Szekanecz Z., The genetic background of ankylosing spondylitis, Joint Bone Spine, 2009, 76, 623-628","DOI":"10.1016\/j.jbspin.2009.02.006"},{"key":"2023040102562795702_j_med-2016-0011_ref_013_w2aab3b8c14b1b7b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Chary-Valckenaere I, d\u2019Agostino MA, Loeuille D. Role for imaging studies in ankylosing spondylitis. Joint Bone Spine. 2011 Mar;78(2):138-143","DOI":"10.1016\/j.jbspin.2010.07.008"},{"key":"2023040102562795702_j_med-2016-0011_ref_014_w2aab3b8c14b1b7b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther. 2006;8(5):R143","DOI":"10.1186\/ar2035"},{"key":"2023040102562795702_j_med-2016-0011_ref_015_w2aab3b8c14b1b7b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Zhang C.-y., Rong R., Wang X.-y., Age-related changes of bone marrow of normal adult man on diffusion weighted imaging, Chin Med Sci J, 2008, 23, 162-165","DOI":"10.1016\/S1001-9294(09)60032-8"},{"key":"2023040102562795702_j_med-2016-0011_ref_016_w2aab3b8c14b1b7b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Kwee T.C., Takahara T., Ochiai R., Katahira K., Van Cauteren M., Imai Y., et al., Whole-body diffusion-weighted magnetic resonance imaging, Eur J Radiol, 2009, 70, 409-417","DOI":"10.1016\/j.ejrad.2009.03.054"},{"key":"2023040102562795702_j_med-2016-0011_ref_017_w2aab3b8c14b1b7b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Bozgeyik Z., Ozgocmen S., Kocakoc E., Role of diffusionweighted MRI in the detection of early active sacroiliitis, Am J Roentgenol, 2008, 191, 980-986","DOI":"10.2214\/AJR.07.3865"},{"key":"2023040102562795702_j_med-2016-0011_ref_018_w2aab3b8c14b1b7b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Machado P., Landew\u00e9 R., Lie E., Kvien T.K., Braun J., Baker D., et al., Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores, Ann Rheum Dis, 2011, 70, 47-53","DOI":"10.1136\/ard.2010.138594"},{"key":"2023040102562795702_j_med-2016-0011_ref_019_w2aab3b8c14b1b7b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Maksymowych W.P., Lambert R.G., Brown L.S., Pangan A.L., Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis, J Rheumatol, 2012, 39, 1666-1674","DOI":"10.3899\/jrheum.120131"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/med\/11\/1\/article-p52.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2016-0011\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2016-0011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T07:30:29Z","timestamp":1680420629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2016-0011\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,6,23]]},"published-print":{"date-parts":[[2016,1,1]]}},"alternative-id":["10.1515\/med-2016-0011"],"URL":"https:\/\/doi.org\/10.1515\/med-2016-0011","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}